v3.26.1
SHARE-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of the components and classification of share-based compensation expense
The following table summarizes the components and classification of the Company’s share-based compensation expenses related to stock options and RSUs for the three and six months ended June 30, 2026 and 2025:

Three Months Ended
June 30,		Six Months Ended
June 30,
(in millions)2026202520262025
Stock options$2 $4 $5 $8 
RSUs 52 42 101 81 
$54 $46 $106 $89 
Research and development expenses$5 $4 $9 $7 
Selling, general and administrative expenses49 42 97 82 
$54 $46 $106 $89 
Schedule of share-based awards
Share-based awards granted for the six months ended June 30, 2026 and 2025 consist of:
Six Months Ended
June 30,
20262025
Bausch Health Share-Based Awards
Time-based RSUs
Granted6,921,000 5,928,000 
Weighted-average grant date fair value$6.06 $7.43 
Performance-based RSUs
Granted2,581,000 2,096,000 
Weighted-average grant date fair value$6.04 $7.36 
Bausch + Lomb Share-Based Awards
Stock options
Granted— 1,374,000 
Weighted-average exercise price$— $15.86 
Weighted-average grant date fair value$— $4.66 
RSUs
Granted3,563,000 3,668,000 
Weighted-average grant date fair value$18.23 $15.45 
TSR PSUs
Granted416,000 388,000 
Weighted-average grant date fair value$18.51 $15.86 
Organic Revenue Growth PSUs
Granted892,000 753,000 
Weighted-average grant date fair value$17.47 $15.98 
Adjusted EBITDA PSUs
Granted416,000 — 
Weighted-average grant date fair value$18.51 $—